Understanding the bases of function and modulation of a7 nicotinic receptors: implications for drug discovery

Molecular Pharmacology

Volumn 90, Issue 3, 2016, Pages 288-299

  Corradi, Jeremías ^a   Bouzat, Cecilia ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; ION; ION CHANNEL;

BINDING SITE; DRUG DESIGN; DRUG SELECTIVITY; EXTRACELLULAR MATRIX; HEALTH STATUS; HUMAN; KINETICS; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PHARMACOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; ALLOSTERIC SITE; ANIMAL; CHEMISTRY; DRUG DEVELOPMENT; METABOLISM; NERVOUS SYSTEM; PATHOLOGY;

ALLOSTERIC SITE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; DRUG DISCOVERY; HUMANS; ION CHANNELS; KINETICS; NERVOUS SYSTEM;

EID: 84985031419     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.116.104240     Document Type: Review

References (184)

1. Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrattenholz A, Barbosa CT, Bonfante-Cabarcas R, Aracava Y, Eisenberg HM, and Maelicke A (1997) Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280: 1117-1136.
2. Albuquerque EX, Pereira EFR, Alkondon M, and Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89:73-120.
3. Althoff T, Hibbs RE, Banerjee S, and Gouaux E (2014) X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors. Nature 512:333-337.
4. Andersen N, Corradi J, Bartos M, Sine SM, and Bouzat C (2011) Functional relationships between agonist binding sites and coupling regions of homomeric Cysloop receptors. J Neurosci 31:3662-3669.
5. Andersen N, Corradi J, Sine SM, and Bouzat C (2013) Stoichiometry for activation of neuronal a7 nicotinic receptors. Proc Natl Acad Sci USA 110:20819-20824.
6. Andersen ND, Nielsen BE, Corradi J, TolosaMF, Feuerbach D, Arias HR, and Bouzat C (2016) Exploring the positive allosteric modulation of human a7 nicotinic receptors from a single-channel perspective. Neuropharmacology 107:189-200.
7. Arias HR and Bouzat C (2010) Activation and modulation of the nicotinic receptor. J Pediatr Biochem 1:53-73.
8. Arias HR, Gu RX, Feuerbach D, Guo B-B, Ye Y, and Wei DQ (2011) Novel positive allosteric modulators of the human a7 nicotinic acetylcholine receptor. Biochemistry 50:5263-5278.
9. Báez-Pagán CA, Delgado-Vélez M, and Lasalde-Dominicci JA (2015) Activation of the macrophage a7 nicotinic acetylcholine receptor and control of inflammation. J Neuroimmune Pharmacol 10:468-476.
10. Bagdas D, Targowska-Duda KM, López JJ, Perez EG, Arias HR, and Damaj MI (2015) The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-ptolyl- Acrylamide, a Positive Allosteric Modulator of a7 Nicotinic Acetylcholine Receptors in Mice. Anesth Analg 121:1369-1377.
11. Bartos M, Corradi J, and Bouzat C (2009) Structural basis of activation of cys-loop receptors: The extracellular-transmembrane interface as a coupling region. Mol Neurobiol 40:236-252.
12. Bertrand D, Bertrand S, Cassar S, Gubbins E, Li J, and Gopalakrishnan M (2008) Positive allosteric modulation of the a7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment. Mol Pharmacol 74:1407-1416.
13. Bertrand D and Gopalakrishnan M (2007) Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol 74:1155-1163.
14. Bitner RS, Bunnelle WH, Decker MW, Drescher KU, Kohlhaas KL, Markosyan S, Marsh KC, Nikkel AL, Browman K, Radek R, et al. (2010) In vivo pharmacological characterization of a novel selective a7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease. J Pharmacol Exp Ther 334:875-886.
15. Bocquet N, Nury H, Baaden M, Le Poupon C, Changeux JP, Delarue M, and Corringer PJ (2009) X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 457:111-114.
16. Boess FG, De Vry J, Erb C, Flessner T, Hendrix M, Luithle J, Methfessel C, Riedl B, Schnizler K, Van Der Staay F, et al. (2007) The Novel a7 Nicotinic Acetylcholine Receptor Agonist benzofuran-2-carboxamide Improves Working and Recognition Memory in Rodents. Pharmacology 321:716-725.
17. Bondarenko V, Mowrey DD, Tillman TS, Seyoum E, Xu Y, and Tang P (2014) NMR structures of the human a7 nAChR transmembrane domain and associated anesthetic binding sites. Biochim Biophys Acta 1838:1389-1395.
18. Bonfante-Cabarcas R, Swanson KL, Alkondon M, and Albuquerque EX (1996) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. IV. Regulation by external Ca11 of alpha-bungarotoxin-sensitive receptor function and of rectification induced by internal Mg11. J Pharmacol Exp Ther 277:432-444.
19. Bouzat C (2012) New insights into the structural bases of activation of Cys-loop receptors. J Physiol Paris 106:23-33.
20. Bouzat C, Bartos M, Corradi J, and Sine SM (2008) The interface between extracellular and transmembrane domains of homomeric Cys-loop receptors governs open-channel lifetime and rate of desensitization. J Neurosci 28:7808-7819.
21. Bouzat C, Gumilar F, Spitzmaul G, Wang HL, Rayes D, Hansen SB, Taylor P, and Sine SM (2004) Coupling of agonist binding to channel gating in an AChbinding protein linked to an ion channel. Nature 430:896-900.
22. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, and Sixma TK (2001) Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411:269-276.
23. Callahan PM, Hutchings EJ, Kille NJ, Chapman JM, and Terry AV Jr (2013) Positive allosteric modulator of a7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates. Neuropharmacology 67:201-212.
24. Castillo M, Mulet J, Bernal JA, Criado M, Sala F, and Sala S (2006) Improved gating of a chimeric alpha7-5HT3A receptor upon mutations at the M2-M3 extracellular loop. FEBS Lett 580:256-260.
25. Castillo M, Mulet J, Gutiérrez LM, Ortiz JA, Castelán F, Gerber S, Sala S, Sala F, and Criado M (2005) Dual role of the RIC-3 protein in trafficking of serotonin and nicotinic acetylcholine receptors. J Biol Chem 280:27062-27068.
26. Cecchini M and Changeux JP (2015) The nicotinic acetylcholine receptor and its prokaryotic homologues: Structure, conformational transitions & allosteric modulation. Neuropharmacology 96 (PtB):137-149.
27. Changeux JP, Kasai M, and Lee CY (1970) Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc Natl Acad Sci USA 67:1241-1247.
28. Chatzidaki A and Millar NS (2015) Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol 97:408-417.
29. Collins T and Millar NS (2010). Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator. Mol Pharmacol 78:198-204.
30. Collins T, Young GT, and Millar NS (2011) Competitive binding at a nicotinic receptor transmembrane site of two a7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization. Neuropharmacology 61: 1306-1313.
31. Corradi J, Andersen N, and Bouzat C (2011) A novel mechanism of modulation of 5-HT3A receptors by hydrocortisone. Biophys J 100:42-51.
32. Corradi J, Gumilar F, and Bouzat C (2009) Single-channel kinetic analysis for activation and desensitization of homomeric 5-HT(3)A receptors. Biophys J 97:1335-1345.
33. Corringer PJ, Poitevin F, Prevost MS, Sauguet L, Delarue M, and Changeux JP (2012) Structure and pharmacology of pentameric receptor channels: from bacteria to brain. Structure 20:941-956.
34. daCosta CJB, Free CR, Corradi J, Bouzat C, and Sine SM (2011) Single-channel and structural foundations of neuronal a7 acetylcholine receptor potentiation. J Neurosci 31:13870-13879.
35. daCosta CJB, Free CR, and Sine SM (2015) Stoichiometry for a-bungarotoxin block of a7 acetylcholine receptors. Nat Commun 6:8057.
36. daCosta CJB and Sine SM (2013) Stoichiometry for drug potentiation of a pentameric ion channel. Proc Natl Acad Sci USA 110:6595-6600.
37. Dajas-Bailador FA, Mogg AJ, and Wonnacott S (2002) Intracellular Ca21 signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca21 channels and Ca21 stores. J Neurochem 81:606-614.
38. Dani JA and Bertrand D (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47:699-729.
39. de Jonge WJ and Ulloa L (2007) The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 151:915-929.
40. Dellisanti CD, Yao Y, Stroud JC, Wang ZZ, and Chen L (2007) Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution. Nat Neurosci 10:953-962.
41. De Rosa MJ, EsandiMdelC, Garelli A, Rayes D, and Bouzat C (2005) Relationship between alpha 7 nAChR and apoptosis in human lymphocytes. J Neuroimmunol 160:154-161.
42. Deutsch SI, Burket JA, Benson AD, and Urbano MR (2016) The 15q13.3 deletion syndrome: Deficient a(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders. Prog Neuropsychopharmacol Biol Psychiatry 64:109-117.
43. Dey R and Chen L (2011) In search of allosteric modulators of a7-nAChR by solvent density guided virtual screening. J Biomol Struct Dyn 28:695-715.
44. Dickinson JA, Kew JNC, and Wonnacott S (2008) Presynaptic alpha 7- And beta 2- containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms. Mol Pharmacol 74:348-359.
45. Dineley KT, Pandya AA, and Yakel JL (2015) Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends Pharmacol Sci 36:96-108.
46. Dinklo T, Shaban H, Thuring JW, Lavreysen H, Stevens KE, Zheng L, Mackie C, Grantham C, Vandenberk I, Meulders G, et al. (2011) Characterization of 2-[[4- fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ- 1930942), a novel positive allosteric modulator of the a7 nicotinic acetylcholine receptor. J Pharmacol Exp Ther 336:560-574.
47. Dunlop J, Lock T, Jow B, Sitzia F, Grauer S, Jow F, Kramer A, Bowlby MR, Randall A, Kowal D, et al. (2009) Old and new pharmacology: positive allosteric modulation of the a7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3, 5-dihydro-5-methyl-N-3-pyridinylbenzo[1, 2-b:4, 5- b9]di pyrrole-1(2H)-carboxamide). J Pharmacol Exp Ther 328:766-776.
48. Egea J, Buendia I, Parada E, Navarro E, León R, and Lopez MG (2015) Antiinflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. Biochem Pharmacol 97:463-472.
49. Feuerbach D, Lingenhoehl K, Olpe HR, Vassout A, Gentsch C, Chaperon F, Nozulak J, Enz A, Bilbe G, McAllister K, et al. (2009) The selective nicotinic acetylcholine receptor a7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology 56:254-263.
50. Feuerbach D, Nozulak J, Lingenhoehl K, McAllister K, and Hoyer D (2007) JN403, in vitro characterization of a novel nicotinic acetylcholine receptor a7 selective agonist. Neurosci Lett 416:61-65.
51. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, and Dunwiddie TV (1998) Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 18:1187-1195.
52. Gill JK, Dhankher P, Sheppard TD, Sher E, and Millar NS (2012) A series of a7 nicotinic acetylcholine receptor allosteric modulators with close chemical similarity but diverse pharmacological properties. Mol Pharmacol 81:710-718.
53. Gill JK, Chatzidaki A, Ursu D, Sher E, and Millar NS (2013) Contrasting properties of a7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors. PLoS One 8:e55047 10.1371/journal.pone.0055047.
54. Gill JK, Savolainen M, Young GT, Zwart R, Sher E, and Millar NS (2011) Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site. Proc Natl Acad Sci USA 108:5867-5872.
55. Gill-Thind JK, Dhankher P, D'Oyley JM, Sheppard TD, and Millar NS (2015) Structurally similar allosteric modulators of a7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects. J Biol Chem 290:3552-3562.
56. Gotti C and Clementi F (2004) Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363-396.
57. Grønlien JH, Ween H, Thorin-Hagene K, Cassar S, Li J, Briggs CA, Gopalakrishnan M, and Malysz J (2010) Importance of M2-M3 loop in governing properties of genistein at the a7 nicotinic acetylcholine receptor inferred from a7/5-HT3A chimera. Eur J Pharmacol 647:37-47.
58. Gu S, Matta JA, Lord B, Harrington AW, Sutton SW, Davini WB, and Bredt DS (2016) Brain a7 Nicotinic Acetylcholine Receptor Assembly Requires NACHO. Neuron 89:948-955.
59. Guan YZ, Jin XD, Guan LX, Yan HC, Wang P, Gong Z, Li SJ, Cao X, Xing YL, and Gao TM (2015) Nicotine inhibits microglial proliferation and is neuroprotective in global ischemia rats. Mol Neurobiol 51:1480-1488.
60. Guan ZZ, Zhang X, Ravid R, and Nordberg A (2000) Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 74:237-243.
61. Guerra-Álvarez M, Moreno-Ortega AJ, Navarro E, Fernández-Morales JC, Egea J, López MG, and Cano-Abad MF (2015) Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(21) release from the endoplasmic reticulum. J Neurochem 133:309-319.
62. Hajós M, Hurst RS, Hoffmann WE, Krause M, Wall TM, Higdon NR, and Groppi VE (2005) The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. J Pharmacol Exp Ther 312:1213-1222.
63. Hansen SB and Taylor P (2007) Galanthamine and non-competitive inhibitor binding to ACh-binding protein: Evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors. J Mol Biol 369:895-901.
64. Hashimoto K (2015) Tropisetron and its targets in Alzheimer's disease. Expert Opin Ther Targets 19:1-5.
65. Hashimoto T, Ichiki T, Watanabe A, Hurt-Camejo E, Michaëlsson E, Ikeda J, Inoue E, Matsuura H, Tokunou T, Kitamoto S, et al. (2014) Stimulation of a7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice. Vascul Pharmacol 61:49-55.
66. Hassaine G, Deluz C, Grasso L, Wyss R, Tol MB, Hovius R, Graff A, Stahlberg H, Tomizaki T, Desmyter A, et al. (2014) X-ray structure of the mouse serotonin 5- HT3 receptor. Nature 512:276-281.
67. Hauser TA, Kucinski A, Jordan KG, Gatto GJ, Wersinger SR, Hesse RA, Stachowiak EK, Stachowiak MK, Papke RL, Lippiello PM, et al. (2009) TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem Pharmacol 78:803-812.
68. Hibbs RE and Gouaux E (2011) Principles of activation and permeation in an anionselective Cys-loop receptor. Nature 474:54-60.
69. Hilf RJC and Dutzler R (2008) X-ray structure of a prokaryotic pentameric ligandgated ion channel. Nature 452:375-379.
70. Hilf RJC and Dutzler R (2009) Structure of a potentially open state of a protonactivated pentameric ligand-gated ion channel. Nature 457:115-118.
71. Hu XQ and Lovinger DM (2008) The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5- hydroxyindole. Neuropharmacology 54:1153-1165.
72. Hurst R, Rollema H, and Bertrand D (2013) Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol Ther 137:22-54.
73. Hurst RS, Hajós M, Raggenbass M, Wall TM, Higdon NR, Lawson JA, Rutherford- Root KL, Berkenpas MB, Hoffmann WE, Piotrowski DW, et al. (2005) A novel positive allosteric modulator of the a7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J Neurosci 25:4396-4405.
74. Iturriaga-Vásquez P, Alzate-Morales J, Bermudez I, Varas R, and Reyes-Parada M (2015) Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy. Pharmacol Res 101:9-17.
75. Jayakar SS, Dailey WP, Eckenhoff RG, and Cohen JB (2013) Identification of propofol binding sites in a nicotinic acetylcholine receptor with a photoreactive propofol analog. J Biol Chem 288:6178-6189.
76. Jones AK, Buckingham SD, and Sattelle DB (2010) Proteins interacting with nicotinic acetylcholine receptors: Expanding functional and therapeutic horizons. Trends Pharmacol Sci 31:455-462.
77. Jones IW and Wonnacott S (2004) Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. J Neurosci 24:11244-11252.
78. Kabbani N, Nordman JC, Corgiat BA, Veltri DP, Shehu A, Seymour VA, and Adams DJ (2013) Are nicotinic acetylcholine receptors coupled to G proteins? BioEssays 35:1025-1034.
79. Kadir A, Almkvist O, Wall A, Långström B, and Nordberg A (2006) PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology (Berl) 188:509-520.
80. Kalappa BI, Sun F, Johnson SR, Jin K, and Uteshev VV (2013) A positive allosteric modulator of a7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia. Br J Pharmacol 169:1862-1878.
81. Karamihalev S, Prickaerts J, and van Goethem NP (2014) Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia. Behav Brain Res 272:248-251.
82. Kawashima K and Fujii T (2004) Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 9:2063-2085.
83. King JR, Nordman JC, Bridges SP, Lin MK, and Kabbani N (2015) Identification and characterization of a G protein-binding cluster in a7 nicotinic acetylcholine receptors. J Biol Chem 290:20060-20070.
84. Langley JN (1905) On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol 33:374-413.
85. Lape R, Colquhoun D, and Sivilotti LG (2008) On the nature of partial agonism in the nicotinic receptor superfamily. Nature 454:722-727.
86. Le Novère N and Changeux JP (2001) LGICdb: The ligand-gated ion channel database. Nucleic Acids Res 29:294-295.
87. Le Novère N and Changeux JP (1995) Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cells. J Mol Evol 40: 155-172.
88. Lee WY and Sine SM (2005) Principal pathway coupling agonist binding to channel gating in nicotinic receptors. Nature 438:243-247.
89. Lendvai B, Kassai F, Szájli A, and Némethy Z (2013) a7 nicotinic acetylcholine receptors and their role in cognition. Brain Res Bull 93:86-96.
90. Lester HA, Dibas MI, Dahan DS, Leite JF, and Dougherty DA (2004) Cys-loop receptors: new twists and turns. Trends Neurosci 27:329-336.
91. Levin ED, Bettegowda C, Blosser J, and Gordon J (1999) AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10:675-680.
92. Li SX, Huang S, Bren N, Noridomi K, Dellisanti CD, Sine SM, and Chen L (2011) Ligand-binding domain of an a7-nicotinic receptor chimera and its complex with agonist. Nat Neurosci 14:1253-1259.
93. Liu Q, Huang Y, Shen J, Steffensen S, and Wu J (2012) Functional a7b2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid b peptides. BMC Neurosci 13:155.
94. Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucero L, Wang M, Sierks M, et al. (2009) A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J Neurosci 29:918-929.
95. Lovinger DM, Sikes S, and Zhou Q (2002) Rapid drug superfusion and kinetic analysis, in Methods in Alcohol-Related Neuroscience Research (Liu Y et al. eds) pp 159-187, CRC Press, Boca Raton, FL.
96. Ludwig J, Höffle-Maas A, Samochocki M, Luttmann E, Albuquerque EX, Fels G, and Maelicke A (2010) Localization by site-directed mutagenesis of a galantamine binding site on a7 nicotinic acetylcholine receptor extracellular domain. J Recept Signal Transduct Res 30:469-483.
97. Mackin KD, Maus AD, Pereira EF, Albuquerque EX, and Conti-Fine BM (1998) Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 287:435-439.
98. Malysz J, Grønlien JH, Anderson DJ, Håkerud M, Thorin-Hagene K, Ween H, Wetterstrand C, Briggs CA, Faghih R, Bunnelle WH, et al. (2009) In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl) benzenesulfonamide (A-867744), exhibiting unique pharmacological profile. J Pharmacol Exp Ther 330:257-267.
99. Martelli D, McKinley MJ, and McAllen RM (2014) The cholinergic anti-inflammatory pathway: A critical review. Auton Neurosci 182:65-69.
100. Maus AD, Pereira EF, Karachunski PI, Horton RM, Navaneetham D, Macklin K, Cortes WS, Albuquerque EX, and Conti-Fine BM (1998) Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 54:779-788.
101. Menze ET, Esmat A, Tadros MG, Abdel-Naim AB, and Khalifa AE (2015) Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties. PLoS One 10:e0117223.
102. Menze ET, Esmat A, Tadros MG, Khalifa AE, and Abdel-Naim AB (2016) Genistein improves sensorimotor gating: Mechanisms related to its neuroprotective effects on the striatum. Neuropharmacology 105:35-46.
103. Mike A, Castro NG, and Albuquerque EX (2000) Choline and acetylcholine have similar kinetic properties of activation and desensitization on the alpha7 nicotinic receptors in rat hippocampal neurons. Brain Res 882:155-168.
104. Miledi R and Potter LT (1971) Acetylcholine receptors in muscle fibres. Nature 233: 599-603.
105. Millar NS (2008) RIC-3: A nicotinic acetylcholine receptor chaperone. Br J Pharmacol 153 (Suppl1):S177-S183.
106. Miller PS and Aricescu AR (2014) Crystal structure of a human GABAA receptor. Nature 512:270-275.
107. Möller-Acuña P, Contreras-Riquelme JS, Rojas-Fuentes C, Nuñez-Vivanco G, Alzate- Morales J, Iturriaga-Vásquez P, Arias HR, and Reyes-Parada M (2015) Similarities between the binding sites of SB-206553 at serotonin type 2 and alpha7 acetylcholine nicotinic receptors: Rationale for its polypharmacological profile. PLoS One 10:e0134444.
108. Monod J, Wyman J, and Changeux JP (1965) On the nature of allosteric transitions: A plausible model. J Mol Biol 12:88-118.
109. Moretti M, Zoli M, George AA, Lukas RJ, Pistillo F, Maskos U, Whiteaker P, and Gotti C (2014) The novel a7b2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization. Mol Pharmacol 86:306-317.
110. Mowrey DD, Liu Q, Bondarenko V, Chen Q, Seyoum E, Xu Y, Wu J, and Tang P (2013) Insights into distinct modulation of a7 and a7b2 nicotinic acetylcholine receptors by the volatile anesthetic isoflurane. J Biol Chem 288:35793-35800.
111. Mukhtasimova N, Lee WY, Wang HL, and Sine SM (2009) Detection and trapping of intermediate states priming nicotinic receptor channel opening. Nature 459: 451-454.
112. Nemecz A and Taylor P (2011) Creating an a7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses. J Biol Chem 286:42555-42565.
113. Neri M, Bonassi S, and Russo P (2012) Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia. Curr Drug Targets 13:636-643.
114. Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, and Gee KW (2007) Nootropic a7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators. Proc Natl Acad Sci USA 104: 8059-8064.
115. Ni M, Yang ZW, Li DJ, Li Q, Zhang SH, Su DF, Xie HH, and Shen FM (2010) A potential role of alpha-7 nicotinic acetylcholine receptor in cardiac angiogenesis in a pressure-overload rat model. J Pharmacol Sci 114:311-319.
116. Nikiforuk A, Kos T, Potasiewicz A, and Popik P (2015) Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. Eur Neuropsychopharmacol 25:1300-1313.
117. Nordman JC and Kabbani N (2012) An interaction between a7 nicotinic receptors and a G-protein pathway complex regulates neurite growth in neural cells. J Cell Sci 125:5502-5513.
118. Nury H, Van Renterghem C, Weng Y, Tran A, Baaden M, Dufresne V, Changeux JP, Sonner JM, Delarue M, and Corringer PJ (2011) X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 469: 428-431.
119. O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, et al. (2010) Discovery of 4-(5-methyloxazolo [4, 5-b]pyridin-2-yl)-1, 4-diazabicyclo[3.2.2]nonane (CP-810, 123), a novel a 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models. J Med Chem 53:1222-1237.
120. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, et al. (2006) Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63:630-638.
121. Pałczy-nska MM, Jindrichova M, Gibb AJ, and Millar NS (2012) Activation of a7 nicotinic receptors by orthosteric and allosteric agonists: influence on singlechannel kinetics and conductance. Mol Pharmacol 82:910-917.
122. Palma E, Bertrand S, Binzoni T, and Bertrand D (1996) Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J Physiol 491:151-161.
123. Papke RL and Porter Papke JK (2002) Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis. Br J Pharmacol 137:49-61.
124. Parada E, Egea J, Buendia I, Negredo P, Cunha AC, Cardoso S, Soares MP, and López MG (2013) The microglial a7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2. Antioxid Redox Signal 19:1135-1148.
125. Park HJ, Lee PH, Ahn YW, Choi YJ, Lee G, Lee DY, Chung ES, and Jin BK (2007) Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur J Neurosci 26:79-89.
126. Patrick J, Ballivet M, Boas L, Claudio T, Forrest J, Ingraham H, Mason P, Stengelin S, Ueno S, and Heinemann S (1983) Molecular cloning of the acetylcholine receptor. Cold Spring Harb Symp Quant Biol 48:71-78.
127. Paulo JA, Brucker WJ, and Hawrot E (2009) Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome. J Proteome Res 8:1849-1858.
128. Pichat P, Bergis OE, Terranova JP, Urani A, Duarte C, Santucci V, Gueudet C, Voltz C, Steinberg R, Stemmelin J, et al. (2007) SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32:17-34.
129. Placzek AN, Grassi F, Papke T, Meyer EM, and Papke RL (2004) A single point mutation confers properties of the muscle-type nicotinic acetylcholine receptor to homomeric alpha7 receptors. Mol Pharmacol 66:169-177.
130. Prickaerts J, van Goethem NP, Chesworth R, Shapiro G, Boess FG, Methfessel C, Reneerkens OAH, Flood DG, Hilt D, Gawryl M, et al. (2012) EVP-6124, a novel and selective a7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of a7 nicotinic acetylcholine receptors. Neuropharmacology 62:1099-1110.
131. Quik M, Zhang D, McGregor M, and Bordia T (2015) Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease. Biochem Pharmacol 97:399-407.
132. Rayes D, De Rosa MJ, Sine SM, and Bouzat C (2009) Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors. J Neurosci 29: 6022-6032.
133. Razani-Boroujerdi S, Boyd RT, Dávila-García MI, Nandi JS, Mishra NC, Singh SP, Pena-Philippides JC, Langley R, and Sopori ML (2007) T cells express alpha7- nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca21 response. J Immunol 179:2889-2898.
134. Sahdeo S, Wallace T, Hirakawa R, Knoflach F, Bertrand D, Maag H, Misner D, Tombaugh GC, Santarelli L, Brameld K, et al. (2014) Characterization of RO5126946, a Novel a7 nicotinic acetylcholine receptor-positive allosteric modulator. J Pharmacol Exp Ther 350:455-468.
135. Sauguet L, Shahsavar A, Poitevin F, Huon C, Menny A, Nemecz À, Haouz A, Changeux JP, Corringer PJ, and Delarue M (2014) Crystal structures of a pentameric ligand-gated ion channel provide a mechanism for activation. Proc Natl Acad Sci USA 111:966-971.
136. Schaaf CP (2014) Nicotinic acetylcholine receptors in human genetic disease. Genet Med 16:649-656.
137. Schirmer SU, Eckhardt I, Lau H, Klein J, DeGraaf YC, Lips KS, Pineau C, Gibbins IL, Kummer W, Meinhardt A, et al. (2011) The cholinergic system in rat testis is of non-neuronal origin. Reproduction 142:157-166.
138. Séguéla P, Wadiche J, Dineley-Miller K, Dani JA, and Patrick JW (1993) Molecular cloning, functional properties, and distribution of rat brain alpha 7: A nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604.
139. Sharma G and Vijayaraghavan S (2001) Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci USA 98:4148-4153.
140. Shen JX and Yakel JL (2012) Functional a7 nicotinic ACh receptors on astrocytes in rat hippocampal CA1 slices. J Mol Neurosci 48:14-21.
141. Shiina A, Shirayama Y, Niitsu T, Hashimoto T, Yoshida T, Hasegawa T, Haraguchi T, Kanahara N, Shiraishi T, Fujisaki M, et al. (2010) A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia. Ann Gen Psychiatry 9:27.
142. Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, Ehrhart J, Silver AA, Sanberg PR, and Tan J (2004) Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89:337-343.
143. Sine SM (2012) End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease. Physiol Rev 92:1189-1234.
144. Sine SM and Engel AG (2006) Recent advances in Cys-loop receptor structure and function. Nature 440:448-455.
145. Sinkus ML, Graw S, Freedman R, Ross RG, Lester HA, and Leonard S (2015) The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function. Neuropharmacology 96 (Pt B):274-288.
146. Sinkus ML, Lee MJ, Gault J, Logel J, Short M, Freedman R, Christian SL, Lyon J, and Leonard S (2009) A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res 1291:1-11.
147. Spurny R, Debaveye S, Farinha A, Veys K, Vos AM, Gossas T, Atack J, Bertrand S, Bertrand D, Danielson UH, et al. (2015) Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the a7 nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 112:E2543-E2552.
148. Stuckenholz V, Bacher M, Balzer-Geldsetzer M, Alvarez-Fischer D, Oertel WH, Dodel RC, and Noelker C (2013) The a7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice. J Parkinsons Dis 3:161-172.
149. Sun F, Jin K, and Uteshev VV (2013) A type-II positive allosteric modulator of a7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats. PLoS One 8:e73581 10.1371/journal.pone.0073581.
150. Sydserff S, Sutton EJ, Song D, Quirk MC, Maciag C, Li C, Jonak G, Gurley D, Gordon JC, Christian EP, et al. (2009) Selective a7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes. Biochem Pharmacol 78:880-888.
151. Szabo AK, Pesti K, Mike A, and Vizi ES (2014) Mode of action of the positive modulator PNU-120596 on a7 nicotinic acetylcholine receptors. Neuropharmacology 81:42-54.
152. Taly A and Changeux JP (2008) Functional organization and conformational dynamics of the nicotinic receptor: A plausible structural interpretation of myasthenic mutations. Ann N Y Acad Sci 1132:42-52.
153. Targowska-Duda KM, Wnorowski A, Budzynska B, Jozwiak K, Biala G, and Arias HR (2016) The positive allosteric modulator of a7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice. Behav Brain Res 302:142-151.
154. Tasneem A, Iyer LM, Jakobsson E, and Aravind L (2005) Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels. Genome Biol 6:R4.
155. Terry AV Jr, Callahan PM, and Hernandez CM (2015) Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders. Biochem Pharmacol 97:388-398.
156. Thomsen MS and Mikkelsen JD (2012) Type I and II positive allosteric modulators differentially modulate agonist-induced up-regulation of a7 nicotinic acetylcholine receptors. J Neurochem 123:73-83.
157. Thomsen MS, Zwart R, Ursu D, Jensen MM, Pinborg LH, Gilmour G, Wu J, Sher E, and Mikkelsen JD (2015) a7 and b2 nicotinic acetylcholine receptor subunits form heteromeric receptor complexes that are expressed in the human cortex and display distinct pharmacological properties. PLoS One 10:e0130572 10.1371/journal. pone.0130572.
158. Timmermann DB, Grønlien JH, Kohlhaas KL, Nielsen EØ, Dam E, Jørgensen TD, Ahring PK, Peters D, Holst D, Christensen JK, et al. (2007) An allosteric modulator of the a7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J Pharmacol Exp Ther 323:294-307.
159. Tsuneki H, Klink R, Léna C, Korn H, and Changeux JP (2000) Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta. Eur J Neurosci 12:2475-2485.
160. Uteshev VV (2014) The therapeutic promise of positive allosteric modulation of nicotinic receptors. Eur J Pharmacol 727:181-185.
161. Uteshev V (2016) Are positive allosteric modulators of a7 nAChRs clinically safe? J Neurochem 136:217-219.
162. Van Kampen M, Selbach K, Schneider R, Schiegel E, Boess F, and Schreiber R (2004) AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors. Psychopharmacology (Berl) 172:375-383.
163. van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, and van der Poll T (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130:1822-1830.
164. Vukelic M, Qing X, Redecha P, Koo G, and Salmon JE (2013) Cholinergic receptors modulate immune complex-induced inflammation in vitro and in vivo. J Immunol 191:1800-1807.
165. Wallace TL and Bertrand D (2013) Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia. Expert Opin Ther Targets 17:139-155.
166. Wallace TL, Callahan PM, Tehim A, Bertrand D, Tombaugh G, Wang S, Xie W, Rowe WB, Ong V, Graham E, et al. (2011) RG3487, a novel nicotinic a7 receptor partial agonist, improves cognition and sensorimotor gating in rodents. J Pharmacol Exp Ther 336:242-253.
167. Wallace TL and Porter RHP (2011) Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochem Pharmacol 82:891-903.
168. Wang Y, Xiao C, Indersmitten T, Freedman R, Leonard S, and Lester HA (2014) The duplicated a7 subunits assemble and form functional nicotinic receptors with the full-length a7. J Biol Chem 289:26451-26463.
169. Wessler I and Kirkpatrick CJ (2008) Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Br J Pharmacol 154:1558-1571.
170. Williams DK, Peng C, Kimbrell MR, and Papke RL (2012) Intrinsically low open probability of a7 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures. Mol Pharmacol 82:746-759.
171. Williams DK, Stokes C, Horenstein NA, and Papke RL (2011a) The effective opening of nicotinic acetylcholine receptors with single agonist binding sites. J Gen Physiol 137:369-384.
172. Williams DK, Wang J, and Papke RL (2011b) Investigation of the molecular mechanism of the a7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states. Mol Pharmacol 80:1013-1032.
173. Williams DK, Wang J, and Papke RL (2011c) Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations. Biochem Pharmacol 82:915-930.
174. Williams ME, Burton B, Urrutia A, Shcherbatko A, Chavez-Noriega LE, Cohen CJ, and Aiyar J (2005) Ric-3 promotes functional expression of the nicotinic acetylcholine receptor alpha7 subunit in mammalian cells. J Biol Chem 280:1257-1263.
175. Wonnacott S and Barik J (2007) Nicotinic ACh Receptors. Tocris Rev 28, http://www.komabiotech.co.kr/pdf/nicotinic-ach-receptors-review.pdf.
176. Yan H, Pan N, Xue F, Zheng Y, Li C, Chang Y, Xu Z, Yang H, and Zhang J (2015) The coupling interface and pore domain codetermine the single-channel activity of the a7 nicotinic receptor. Neuropharmacology 95:448-458.
177. Yang JS, Seo SW, Jang S, Jung GY, and Kim S (2012) Rational engineering of enzyme allosteric regulation through sequence evolution analysis. PLOS Comput Biol 8:e1002612 10.1371/journal.pcbi.1002612.
178. Young GT, Zwart R, Walker AS, Sher E, and Millar NS (2008) Potentiation of a7 nicotinic acetylcholine receptors via an allosteric transmembrane site. Proc Natl Acad Sci USA 105:14686-14691.
179. Zdanowski R, Krzy-zowska M, Ujazdowska D, Lewicka A, and Lewicki S (2015) Role of a7 nicotinic receptor in the immune system and intracellular signaling pathways. Cent Eur J Immunol 40:373-379.
180. Zhang J, Xue F, Liu Y, Yang H, and Wang X (2013) The structural mechanism of the Cys-loop receptor desensitization. Mol Neurobiol 48:97-108.
181. Zhou Q, Verdoorn TA, and Lovinger DM (1998) Alcohols potentiate the function of 5-HT3 receptor-channels on NCB-20 neuroblastoma cells by favouring and stabilizing the open channel state. J Physiol 507:335-352.
182. Zia S, Ndoye A, Nguyen VT, and Grando SA (1997) Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 97:243-262.
183. Zimmermann I, Marabelli A, Bertozzi C, Sivilotti LG, and Dutzler R (2012) Inhibition of the prokaryotic pentameric ligand-gated ion channel ELIC by divalent cations. PLoS Biol 10:e1001429.
184. Zoli M, Pistillo F, and Gotti C (2015) Diversity of native nicotinic receptor subtypes in mammalian brain. Neuropharmacology 96 (Pt B):302-311.